We’re looking forward to kicking off the autumn program for our global innovation program.
Stay tuned!
We’re looking forward to kicking off the autumn program for our global innovation program.
Stay tuned!
On June 19th, Startup Creasphere hosted the much-awaited annual event dedicated to the healthcare ecosystem. Celebrating 5 years of innovation, the EXPO10 brought together industry leaders, corporations, startups and entrepreneurs, in a vibrant showcase of technological transformation.
The healthcare industry has been one of the last men standing in terms of digital transformation. But innovations such as telemedicine, remote patient monitoring, digital biomarkers and more have led doctors, patients, hospitals, and insurance carriers to rethink the relationship between medicine, healthcare and technology.
A joint Roche & FibriCheck team explored how digital solutions such as the FibriCheck app can add value in the AF patient journey, e.g. screening for undiagnosed atrial fibrillation patients.
Roche has collaborated with Lark Health on the pilot study “Cardiac Self-Efficacy Improvement in a Digital Health Pilot Program for Heart Health” to help patients prevent and manage heart disease by targeting Cardiovascular Disease risk factors.
Roche has collaborated with STARTUP CREASHERE to identify partners for a digital platform for HCPs at the PoC to improve workflows and change healthcare in favour of cost efficiency and better patient care.
SagivTech, is a company specializing in artificial intelligence (AI), image processing, and computer vision, founded in 2009 by Chen Sagiv and Nizan Sagiv in Israel.
MUNICH, GERMANY. On February 2, Startup Creasphere welcomed the global digital health ecosystem, leading healthcare corporations, investors, startups, and other stakeholders to EXPO 9.
MUNICH, GERMANY. Oct 5, 2022. Startup Creasphere welcomed two new partners to the global digital health platform: Daiichi Sankyo Europe and BI X. On top, Roche Diagnostics and BIOTRONIK selected eight startups for Batch 9 that will work with their business units during this winter.
At Plug and Play, we are excited about our strong global partnership with Roche and our joint mission to transform healthcare together. For the most recent 3 month program (Batch 8), Roche business units have been collaborating with Cerascreen, Decentriq, MediBioSense, Neurotrack, and PxHealthcare.
Cardiovascular Diseases (CVDs) are the leading cause of death worldwide with an estimated 18M fatalities annually and covering 30% of all fatalities on a global scale. The most common CVDs include coronary heart disease, cerebrovascular disease, and rheumatic heart disease.
